These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 32174789)
21. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related]
22. PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway. Zhou S; Wang B; Wei Y; Dai P; Chen Y; Xiao Y; Xia H; Chen C; Yin W Cancer Biomark; 2024; 40(1):47-59. PubMed ID: 38306024 [TBL] [Abstract][Full Text] [Related]
23. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway. Dirican A; Atmaca H; Bozkurt E; Erten C; Karaca B; Uslu R Clin Transl Oncol; 2015 Feb; 17(2):145-51. PubMed ID: 25060568 [TBL] [Abstract][Full Text] [Related]
24. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
25. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer]. Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602 [TBL] [Abstract][Full Text] [Related]
26. Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway. Zhu S; Jiao W; Xu Y; Hou L; Li H; Shao J; Zhang X; Wang R; Kong D Life Sci; 2021 Dec; 286():120046. PubMed ID: 34653428 [TBL] [Abstract][Full Text] [Related]
27. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models. Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373 [TBL] [Abstract][Full Text] [Related]
28. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201 [TBL] [Abstract][Full Text] [Related]
29. Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells. Qian S; Fang H; Zheng L; Liu M J Biochem Mol Toxicol; 2021 Jan; 35(1):e22611. PubMed ID: 32905641 [TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic Acid Reverses Epithelial-Mesenchymal Transition and Drug Resistance by Impairing the PI3K/AKT/ Nrf2/GPX4 Signalling Pathway in Docetaxel-Resistant PC3 Prostate Cancer Cells. Shao ZC; Zhu BH; Huang AF; Su MQ; An LJ; Wu ZP; Jiang YJ; Guo H; Han XQ; Liu CM Folia Biol (Praha); 2022; 68(2):59-71. PubMed ID: 36384263 [TBL] [Abstract][Full Text] [Related]
31. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway. Zhang X; Shao J; Li X; Cui L; Tan Z Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804 [TBL] [Abstract][Full Text] [Related]
32. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398 [TBL] [Abstract][Full Text] [Related]
33. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling. Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357 [TBL] [Abstract][Full Text] [Related]
34. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways. Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731 [TBL] [Abstract][Full Text] [Related]
35. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. Wu C; Qiu S; Liu P; Ge Y; Gao X J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890 [TBL] [Abstract][Full Text] [Related]
36. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer. Liu Z; Zhu G; Getzenberg RH; Veltri RW J Cell Biochem; 2015 Jul; 116(7):1341-9. PubMed ID: 25640606 [TBL] [Abstract][Full Text] [Related]
37. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling. Huang SH; Tseng JC; Lin CY; Kuo YY; Wang BJ; Kao YH; Muller CJF; Joubert E; Chuu CP Phytomedicine; 2019 Nov; 64():153068. PubMed ID: 31419729 [TBL] [Abstract][Full Text] [Related]
38. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975 [TBL] [Abstract][Full Text] [Related]